Tag Archives: After

Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?

Merck hasn’t exactly made a fortune on its $ 9.5 billion Cubist Pharmaceuticals buyout, but now, a next-gen antibiotic it acquired in that deal has a brand-new indication that could help jump-start sales. On Monday, the FDA approved that drug, Zerbaxa, to treat adults with hospital-acquired and ventilator-associated pneumonia. It’s an add-on to Zerbaxa’s original approvals—to treat complicated… Read More »

What’s the Deal With Crying After Sex?

Consensual sex with a partner you’re into is supposed to make you feel a lot of things, like sexy, close, ecstatic, blissed out, warm, relaxed… All good stuff. But, thanks to a growing area of research, we now know that about half of all sex-having people feel a flurry of negative emotions, instead. Those post-sex… Read More »

Returning to Racing After an Injury

Welcome to the Running newsletter! Every Saturday morning, we email runners with news, advice and some motivation to help you get up and running. Sign up here to get it in your inbox. On Tuesday, I ran my first race since a stress fracture had sidelined me from running for 84 days. I’ve been running… Read More »